Literature DB >> 21314677

Amphetamine-associated seizures: clinical features and prognosis.

J William L Brown1, John W Dunne, Daniel M Fatovich, Daniel M Fatovic, Judy Lee, Nicholas D Lawn.   

Abstract

Forty-four patients presenting with first-ever seizure within 24 h of illicit use of amphetamine or related analogs (amphetamine-associated seizures, AAS) were identified over 8 years. Patients with AAS were compared to control groups of other first-ever seizure patients (provoked n = 126 and unprovoked n = 401). Cumulative probability of recurrence was calculated using Kaplan-Meier analysis. Seizure recurrence and development of epilepsy were less likely in patients with AAS compared to provoked or unprovoked controls. Forty percent of patients with AAS had clinical risk factors for epilepsy, epileptiform abnormalities on electroencephalography (EEG), or an epileptogenic lesion on neuroimaging. Sleep deprivation was more frequently present in those with AAS. AAS likely relate to an intrinsic proconvulsant effect of these drugs combined with patient susceptibility and environmental factors. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21314677     DOI: 10.1111/j.1528-1167.2010.02924.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

Review 1.  National Association of Medical Examiners position paper: Recommendations for the investigation and certification of deaths in people with epilepsy.

Authors:  Owen Middleton; Daniel Atherton; Elizabeth Bundock; Elizabeth Donner; Daniel Friedman; Dale Hesdorffer; Heather Jarrell; Aileen McCrillis; Othon J Mena; Mitchel Morey; David Thurman; Niu Tian; Torbjörn Tomson; Zian Tseng; Steven White; Cyndi Wright; Orrin Devinsky
Journal:  Epilepsia       Date:  2018-03-01       Impact factor: 5.864

Review 2.  A review of basic to clinical studies of the association between hyperammonemia, methamphetamine.

Authors:  Marzieh Jafari Fakharbad; Mohammad Moshiri; Mohammad Mehdi Ommati; Mehdi Talebi; Leila Etemad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-23       Impact factor: 3.195

Review 3.  DARK Classics in Chemical Neuroscience: Aminorex Analogues.

Authors:  Julian Maier; Felix P Mayer; Simon D Brandt; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2018-10-05       Impact factor: 5.780

4.  External validation of a prognostic model for seizure recurrence following a first unprovoked seizure and implications for driving.

Authors:  Laura Jayne Bonnett; Anthony G Marson; Anthony Johnson; Lois Kim; Josemir W Sander; Nicholas Lawn; Ettore Beghi; Maurizio Leone; Catrin Tudur Smith
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.